Advisor OS LLC Sells 185 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Advisor OS LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 15.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,013 shares of the company’s stock after selling 185 shares during the period. Advisor OS [...]

featured-image

Advisor OS LLC lessened its position in shares of HCA Healthcare, Inc. ( NYSE:HCA – Free Report ) by 15.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.

The firm owned 1,013 shares of the company’s stock after selling 185 shares during the period. Advisor OS LLC’s holdings in HCA Healthcare were worth $325,000 at the end of the most recent quarter. Several other large investors have also recently added to or reduced their stakes in the company.



CreativeOne Wealth LLC bought a new stake in HCA Healthcare during the first quarter worth $231,000. New Mexico Educational Retirement Board increased its position in shares of HCA Healthcare by 29.9% during the first quarter.

New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares during the period. Apexium Financial LP acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $361,000. Sanders Capital LLC boosted its holdings in shares of HCA Healthcare by 4.

2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares in the last quarter. Finally, KBC Group NV increased its stake in HCA Healthcare by 60.

6% in the fourth quarter. KBC Group NV now owns 365,984 shares of the company’s stock valued at $99,065,000 after purchasing an additional 138,146 shares in the last quarter. Institutional investors own 62.

73% of the company’s stock. Wall Street Analysts Forecast Growth Several brokerages recently weighed in on HCA. UBS Group raised their price target on shares of HCA Healthcare from $405.

00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Robert W.

Baird initiated coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock.

JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $327.00 to $332.

00 and gave the company a “neutral” rating in a research note on Thursday, May 30th. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.

00 target price on the stock. Finally, Leerink Partners raised their price target on HCA Healthcare from $367.00 to $396.

00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $359.

89. HCA Healthcare Price Performance HCA opened at $387.98 on Monday.

The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.

06. HCA Healthcare, Inc. has a 52-week low of $215.

96 and a 52-week high of $403.05. The stock has a market capitalization of $101.

62 billion, a PE ratio of 19.34, a price-to-earnings-growth ratio of 1.52 and a beta of 1.

67. The stock’s 50 day moving average price is $355.43 and its 200-day moving average price is $336.

01. HCA Healthcare ( NYSE:HCA – Get Free Report ) last posted its earnings results on Tuesday, July 23rd. The company reported $5.

50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53.

HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%.

The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion.

During the same period in the previous year, the firm earned $4.29 earnings per share. The business’s revenue was up 10.

3% compared to the same quarter last year. On average, equities research analysts predict that HCA Healthcare, Inc. will post 22.

5 EPS for the current year. HCA Healthcare Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be paid a $0.

66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.

64 annualized dividend and a yield of 0.68%. HCA Healthcare’s payout ratio is 13.

16%. Insider Buying and Selling In related news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th.

The stock was sold at an average price of $360.20, for a total value of $1,440,800.00.

Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website .

In other news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.

51, for a total value of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.

54. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink . Also, SVP Christopher F.

Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.

00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80.

The disclosure for this sale can be found here . Insiders have sold a total of 8,844 shares of company stock valued at $3,185,932 over the last ninety days. Company insiders own 1.

60% of the company’s stock. About HCA Healthcare ( Free Report ) HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. ( NYSE:HCA – Free Report ).

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter ..